The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that often presents clinically at an advanced stage and that may be confused with chronic pancreatitis (CP). Conversely, CP may be misdiagnosed as PDAC leading to unwarranted pancreas resection. Therefore, early PDAC diagnosis and clear differentiation between PDAC and CP are crucial for improved care. Exosomes are circulating microvesicles whose components can serve as cancer biomarkers. We compared exosomal glypican-1 (GPC1) and microRNA levels in normal control subjects and in patients with PDAC and CP. We report that exosomal GPC1 is not diagnostic for PDAC, whereas high exosomal levels of microRNA-10b, (miR-10b), miR-21, miR-30c, and miR-181a and low miR-let7a readily differentiate PDAC from normal control and CP samples. By contrast with GPC1, elevated exosomal miR levels decreased to normal values within 24 h following PDAC resection. All 29 PDAC cases exhibited significantly elevated exosomal miR-10b and miR-30c levels, whereas 8 cases had normal or slightly increased CA 19-9 levels. Thus, our exosomal miR signature is superior to exosomal GPC1 or plasma CA 19-9 levels in establishing a diagnosis of PDAC and differentiating between PDAC and CP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,757
Wiklander, O. P. B., Nordin, J. Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mäger, I., Vader, P., Lee, Y., Sork, H., Seow, Y., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26316 · Cited by 1,730
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,697
Bloomston, M., Frankel, W. L., Petrocca, F., Volinia, S., Alder, H., Hagan, J. P., Liu, C.-G., Bhatt, D., Taccioli, C., & Croce, C. M. (2007) · JAMA · doi:10.1001/jama.297.17.1901 · Cited by 1,141
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Iorio, M. V., & Croce, C. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0317 · Cited by 959
van der Pol, E., Coumans, F. A. W., Grootemaat, A. E., Gardiner, C., Sargent, I. L., Harrison, P., Sturk, A., van Leeuwen, T. G., & Nieuwland, R. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12602 · Cited by 917
Christianson, H. C., Svensson, K. J., van Kuppevelt, T. H., Li, J.-P., & Belting, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304266110 · Cited by 903
Expression profiling identifies microRNA signature in pancreatic cancer
Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., Morgan, D. L., Postier, R. G., Brackett, D. J., & Schmittgen, T. D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22394 · Cited by 896
Classification of pancreatitis.
Sarner, M., & Cotton, P. B. (1984) · Gut · doi:10.1136/gut.25.7.756 · Cited by 699
Heparan sulphate proteoglycans: the sweet side of development
Häcker, U., Nybakken, K., & Perrimon, N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1681 · Cited by 683
Imai, T., Takahashi, Y., Nishikawa, M., Kato, K., Morishita, M., Yamashita, T., Matsumoto, A., Charoenviriyakul, C., & Takakura, Y. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26238 · Cited by 579
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Ardito, C. M., Grüner, B. M., Takeuchi, K. K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P. K., DelGiorno, K. E., Carpenter, E. S., Halbrook, C. J., Hall, J. C., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.024 · Cited by 517
miRNA in Plasma Exosome is Stable under Different Storage Conditions
Ge, Q., Zhou, Y., Lu, J., Bai, Y., Xie, X., & Lu, Z. (2014) · Molecules · doi:10.3390/molecules19021568 · Cited by 475
Greither, T., Grochola, L. F., Udelnow, A., Lautenschläger, C., Würl, P., & Taubert, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24687 · Cited by 448
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
Navas, C., Hernández-Porras, I., Schuhmacher, A. J., Sibilia, M., Guerra, C., & Barbacid, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.001 · Cited by 391
Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Büchler, M. W., Lander, A. D., & Korc, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4105 · Cited by 368
Self-citationPhilip, P. A., Mooney, M., Jaffe, D., Eckhardt, G., Moore, M., Meropol, N., Emens, L., O'Reilly, E., Korc, M., Ellis, L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9022 · Cited by 240
Self-citationAnalysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues
Szafranska, A. E., Doleshal, M., Edmunds, H. S., Gordon, S., Luttges, J., Munding, J. B., Barth, R. J., Gutmann, E. J., Suriawinata, A. A., Marc Pipas, J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109603 · Cited by 220
Self-citationMicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
du Rieu, M. C., Torrisani, J., Selves, J., Al Saati, T., Souque, A., Dufresne, M., Tsongalis, G. J., Suriawinata, A. A., Carrère, N., Buscail, L., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.137364 · Cited by 217
Heparan sulfate signaling in cancer
Knelson, E. H., Nee, J. C., & Blobe, G. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.001 · Cited by 197
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
Aikawa, T., Whipple, C. A., Lopez, M. E., Gunn, J., Young, A., Lander, A. D., & Korc, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32412 · Cited by 189
Self-citationThe heparanome—The enigma of encoding and decoding heparan sulfate sulfation
Lamanna, W. C., Kalus, I., Padva, M., Baldwin, R. J., Merry, C. L. R., & Dierks, T. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.01.022 · Cited by 179
Coumans, F. A. W., van der Pol, E., Böing, A. N., Hajji, N., Sturk, G., van Leeuwen, T. G., & Nieuwland, R. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.25922 · Cited by 171
Heparan Sulfate Proteoglycans as Adhesive and Anti-invasive Molecules
Liu, W., Litwack, E. D., Stanley, M. J., Langford, J. K., Lander, A. D., & Sanderson, R. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22825 · Cited by 168
Ouyang, H., Gore, J., McElyea, S. D., & Korc, M. (2013) · Oncogene · doi:10.1038/onc.2013.405 · Cited by 159
Self-citationPreis, M., Gardner, T. B., Gordon, S. R., Pipas, J. M., Mackenzie, T. A., Klein, E. E., Longnecker, D. S., Gutmann, E. J., Sempere, L. F., & Korc, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0695 · Cited by 159
Self-citationProteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion
Mythreye, K., & Blobe, G. C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.05.001 · Cited by 141
Coté, G. A., Gore, J., McElyea, S. D., Heathers, L., Xu, H., Sherman, S., & Korc, M. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.331 · Cited by 139
Self-citationSempere, L., Preis, M., Yezefski, T., Ouyang, H.-X., Suriawinata, A., Silahtaroglu, A., Conejo-Garcia, J., Kauppinen, S., Wells, W., & Korc, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1152 · Cited by 109
Self-citationThe role of endoscopy in benign pancreatic disease
Chandrasekhara, V., Chathadi, K. V., Acosta, R. D., Decker, G. A., Early, D. S., Eloubeidi, M. A., Evans, J. A., Faulx, A. L., Fanelli, R. D., Fisher, D. A., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.04.022 · Cited by 95
Epigenetic Regulation of miRNAs in Cancer
Fabbri, M., Calore, F., Paone, A., Galli, R., & Călin, G. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_6 · Cited by 93
Heparan sulfate proteoglycans: A GAGgle of skeletal‐hematopoietic regulators
Bungartz, K. D., Antonio, J. D. S., & Jacenko, O. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21593 · Cited by 86
Up-regulation of Transforming Growth Factor (TGF)-β Receptors by TGF-β1 in COLO-357 Cells
Kleeff, J. H., & Korc, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7495 · Cited by 78
Self-citationWhipple, C. A., Young, A. L., & Korc, M. (2011) · Oncogene · doi:10.1038/onc.2011.430 · Cited by 78
Self-citationA Novel TIP30 Protein Complex Regulates EGF Receptor Signaling and Endocytic Degradation
Zhang, C., Li, A., Zhang, X., & Xiao, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.207720 · Cited by 56
The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer
Johansen, J. S., Calatayud, D., Albieri, V., Schultz, N. A., Dehlendorff, C., Werner, J., Jensen, B. V., Pfeiffer, P., Bojesen, S. E., Giese, N., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30291 · Cited by 47
Ray, K. C., Moss, M. E., Franklin, J. L., Weaver, C., Higginbotham, J. N., Song, Y., Revetta, F. L., Blaine, S. A., Bridges, L., Guess, K. E., et al. (2013) · Oncogene · doi:10.1038/onc.2013.3 · Cited by 46
Cited by
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
Exosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249
Exosomes in cancer development, metastasis, and immunity
Zhang, L., & Yu, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.004 · Cited by 870
Molecular interactions at the surface of extracellular vesicles
Buzás, E. I., Tóth, E. Á., Sódar, B. W., & Szabó-Taylor, K. É. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0682-0 · Cited by 375
Metadata
- Authors
- Lai, X., Wang, M., McElyea, S. D., Sherman, S., House, M., & Korc, M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 393
- Pages
- 86-93
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2589546201
- Cited by
- 383
- References
- 52
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.